VVP
CVS icon

Venture Visionary Partners’s CVS Health CVS Stock Holding History

Venture Visionary Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$897K Buy
10,465
+280
+3% +$27.4K 0.02% 373
2026
Q2 		$1.05M Buy
10,185
+73
+0.7% +$6.52K 0.03% 336
2026
Q1 		$726K Buy
10,112
+609
+6% +$46.9K 0.02% 362
2025
Q4 		$754K Sell
9,503
-522
-5% -$41.2K 0.02% 361
2025
Q3 		$756K Buy
10,025
+9
+0.1% +$617 0.03% 337
2025
Q2 		$691K Buy
10,016
+3
+0% +$197 0.03% 338
2025
Q1 		$678K Sell
10,013
-154
-2% -$9.22K 0.03% 330
2024
Q4 		$456K Sell
10,167
-3,707
-27% -$208K 0.02% 389
2024
Q3 		$872K Sell
13,874
-1,113
-7% -$64.9K 0.04% 290
2024
Q2 		$885K Buy
14,987
+309
+2% +$19.3K 0.04% 287
2024
Q1 		$1.17M Buy
14,678
+140
+1% +$10.7K 0.06% 257
2023
Q4 		$1.15M Buy
14,538
+39
+0.3% +$2.78K 0.06% 239
2023
Q3 		$1.01M Buy
14,499
+16
+0.1% +$1.13K 0.06% 244
2023
Q2 		$1M Sell
14,483
-557
-4% -$39.6K 0.06% 243
2023
Q1 		$1.12M Sell
15,040
-680
-4% -$57K 0.07% 216
2022
Q4 		$1.46M Sell
15,720
-11
-0.1% -$1.06K 0.11% 169
2022
Q3 		$1.5M Buy
15,731
+583
+4% +$57.7K 0.12% 148
2022
Q2 		$1.4M Buy
15,148
+402
+3% +$39.2K 0.11% 159
2022
Q1 		$1.49M Sell
14,746
-266
-2% -$27.9K 0.1% 172
2021
Q4 		$1.54M Buy
15,012
+1,034
+7% +$95.5K 0.1% 170
2021
Q3 		$1.19M Sell
13,978
-3,553
-20% -$298K 0.08% 190
2021
Q2 		$1.46M Sell
17,531
-5,815
-25% -$476K 0.12% 162
2021
Q1 		$1.76M Buy
23,346
+3,047
+15% +$222K 0.15% 129
2020
Q4 		$1.39M Buy
20,299
+15,921
+364% +$1.04M 0.15% 115
2020
Q3 		$270K Buy
+4,378
New +$272K 0.07% 158

Other funds holding CVS

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Venture Visionary Partners's CVS Position: Q3 2026 in Review

Venture Visionary Partners increased its CVS Health (CVS) stake by 2.7% in Q3 2026, buying an estimated $27.4K and bringing the position to 10,465 shares worth $897K. The position accounts for 0.02% of the portfolio, ranked #373.

Venture Visionary Partners first reported a position in CVS in Q3 2020 and has held it in 25 quarters since. The position peaked at $1.76M in Q1 2021. 93 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Venture Visionary Partners held 10,465 shares of CVS Health worth $897K as of Q3 2026.
  • Venture Visionary Partners bought 280 CVS Health shares in Q3 2026, an estimated $27.4K.
  • CVS Health made up 0.02% of Venture Visionary Partners's portfolio in Q3 2026, its #373 holding.
  • Venture Visionary Partners first reported a position in CVS Health in Q3 2020 and has held it in 25 quarters since.
  • Venture Visionary Partners's CVS Health position peaked at $1.76M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.